{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:37:53Z","timestamp":1781663873427,"version":"3.54.5"},"reference-count":22,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Introduction: Peritoneal dialysis and continuous renal replacement therapy (CRRT) are the most frequently used treatment modalities for acute kidney injury. CRRT is currently being used for the treatment of several non-renal indications, such as congenital metabolic diseases. CRRT can efficiently remove toxic metabolites and reverse the neurological symptoms quickly. However, there is not enough data for CRRT in children with metabolic diseases. Therefore, we aimed a retrospective study to describe the use of CRRT in metabolic diseases and its associated efficacy, complications, and outcomes. Materials and Methods: We performed a retrospective analysis of the records of all patients admitted in the pediatric intensive care unit (PICU) for CRRT treatment. Results: Between December 2014 and November 2018, 97 patients were eligible for the present study. The age distribution was between 2 days and 17 years, with a mean of 3.77 \u00b1 4.71 years. There were 13 (36.1%) newborn with metabolic diseases. The patients were divided into two groups: CRRT for metabolic diseases and others. There was a significant relationship between the groups, including age (p \u2264 0.001), weight (p = 0.028), blood flow rate (p \u2264 0.001); dialysate rate (p \u2264 0.001), and replacement rate (p \u2264 0.001). The leucine reduction rate was 3.88 \u00b1 3.65 (% per hour). The ammonia reduction rate was 4.94 \u00b1 5.05 in the urea cycle disorder group and 5.02 \u00b1 4.54 in the organic acidemia group. The overall survival rate was 88.9% in metabolic diseases with CRRT. Conclusion: In particularly hemodynamically unstable patients, CRRT can effectively and quickly reduce plasma ammonia and leucine.<\/jats:p>","DOI":"10.3390\/children6040053","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T11:31:57Z","timestamp":1554377517000},"page":"53","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Continuous Renal Replacement Therapy with High Flow Rate Can Effectively, Safely, and Quickly Reduce Plasma Ammonia and Leucine Levels in Children"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6519-6583","authenticated-orcid":false,"given":"Fatih","family":"Aygun","sequence":"first","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Fatih, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Varol","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Fatih, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7256-0750","authenticated-orcid":false,"given":"Cigdem","family":"Aktuglu-Zeybek","sequence":"additional","affiliation":[{"name":"Division of Nutrition and Metabolism, Department of Pediatrics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ertugrul","family":"Kiykim","sequence":"additional","affiliation":[{"name":"Division of Nutrition and Metabolism, Department of Pediatrics, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halit","family":"Cam","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care Unit, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Fatih, Istanbul 34098, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcrc.2013.09.008","article-title":"Indications and outcomes in children receiving renal replacement therapy in pediatric intensive care","volume":"29","author":"Boschee","year":"2014","journal-title":"J. Crit. Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000492660","article-title":"Abstract Optimal Prescriptions of Continuous Renal Replacement Therapy in Neonates with Hyperammonemia","volume":"47","author":"Kim","year":"2019","journal-title":"Blood Purif."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1651-2227.1995.tb13673.x","article-title":"Two cases suggesting a role for the L-arginine nitric oxide pathway in neonatal blood pressure regulation","volume":"84","author":"Fakler","year":"1995","journal-title":"Acta Paediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/BF01477940","article-title":"Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients\u2019 resistant to diuretics","volume":"55","author":"Kramer","year":"1977","journal-title":"Klin. Wochenschr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"R205","DOI":"10.1186\/cc11835","article-title":"Optimal Mode of clearance in critically ill patients with acute kidney injury (OMAKI)\u2014A pilot randomized controlled trial of hemofiltration versus hemodialysis: A Canadian Critical Care Trials Group project","volume":"16","author":"Wald","year":"2012","journal-title":"Crit. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s00467-006-0044-3","article-title":"Duration of extracorporeal therapy in acute maple syrup urine disease: A kinetic model","volume":"21","author":"Phan","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00467-013-2441-8","article-title":"High-dose continuous renal replacement therapy for neonatal hyperammonemia","volume":"28","author":"Spinale","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"ref_8","first-page":"74","article-title":"Continuous venovenous hemofiltration in neonates with hyperammonemia. A case series","volume":"89","year":"2018","journal-title":"Rev. Chil. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.pedneo.2017.11.015","article-title":"Renal Replacement Therapy in the Neonatal Intensive Care Unit","volume":"59","author":"Tseng","year":"2018","journal-title":"Pediatr. Neonatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/brain\/awp024","article-title":"Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease","volume":"132","author":"Zinnanti","year":"2009","journal-title":"Brain"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pedneo.2017.04.004","article-title":"The impact of continuous renal replacement therapy for metabolic disorders in infants","volume":"59","author":"Aygun","year":"2018","journal-title":"Pediatr. Neonatol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Cho, H. (2018). Renal replacement therapy in neonates with an inborn error of metabolism. Korean J. Pediatr.","DOI":"10.3345\/kjp.2018.07143"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jpeds.2004.01.037","article-title":"Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency","volume":"144","author":"McBryde","year":"2004","journal-title":"J. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders","volume":"7","author":"Boddaert","year":"2012","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s004670100702","article-title":"Extracorporeal dialysis in neonatal hyperammonemia: Modalities and prognostic indicators","volume":"16","author":"Picca","year":"2001","journal-title":"Pediatr. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00467-013-2638-x","article-title":"A biphasic dialytic strategy for the treatment of neonatal hyperammonemia","volume":"29","author":"Hanudel","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2215\/CJN.01320216","article-title":"The Role of RRT in Hyperammonemic Patients","volume":"11","author":"Gupta","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Yetimakman, A.F., Kesici, S., Tanyildiz, M., Bayrakci, U.S., and Bayrakci, B.A. (2017). Report of 7-Year Experience on Pediatric Continuous Renal Replacement Therapy. J. Intensiv. Care Med.","DOI":"10.1177\/0885066617724339"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jpeds.2006.01.004","article-title":"Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism","volume":"148","author":"McBryde","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM198406073102304","article-title":"Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies","volume":"310","author":"Msall","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/ndt\/14.4.910","article-title":"Dialysis in neonates with inborn errors of metabolism","volume":"14","author":"Schaefer","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000443783","article-title":"Continuous Venovenous Hemodiafiltration in the Treatment of Maple Syrup Urine Disease","volume":"42","author":"Demirkol","year":"2016","journal-title":"Blood Purif."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/6\/4\/53\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:42:58Z","timestamp":1760186578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/6\/4\/53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["children6040053"],"URL":"https:\/\/doi.org\/10.3390\/children6040053","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]}}}